- |||||||||| Journal: GDF5 as a rejuvenating treatment for age-related neuromuscular failure. (Pubmed Central) - Nov 3, 2024
In addition, in human muscle biopsies, we found the same age-related alterations than those observed in mice and improved by GDF5 and reproduced its major effects on human cells, suggesting this treatment as efficient in humans. Overall, these data provide a foundation to examine the curative potential of GDF5 drug in clinical trials for sarcopenia and, eventually, other neuromuscular diseases.
- |||||||||| Improving delivery of exercise in oncology: an implementation science approach (Arena 1B) - Nov 3, 2024 - Abstract #COSA2024COSA_269;
Implementation science is the scientific study of strategies to promote the use of evidence-based practices in routine clinical care. I will explore common barriers to exercise delivery and provide implementation science-informed solutions for success.
- |||||||||| Review, Journal: Experimental models as a tool for research on sarcopenia: a narrative review. (Pubmed Central) - Nov 2, 2024
We will summarize the literature and present relevant experimental models in terms of their advantages and disadvantages. All of the presented approaches could potentially contribute to the accurate and early diagnosis, follow-up, and possible treatment of sarcopenia.
- |||||||||| Biomarker, Retrospective data, Review, Journal: Effectiveness of resistance training on body composition, muscle strength, and biomarker in sarcopenic older adults: A meta-analysis of randomized controlled trials. (Pubmed Central) - Nov 2, 2024
Regarding biomarkers, RT had a medium effect size on insulin-like growth factor-1 (SMD = 0.70[0.10,1.30]), interleukin-10 (SMD = 0.61[0.09,1.13]), follistatin (SMD = 0.56[0.16,0.96]), but no effect on interleukin-6, tumor necrosis factor-alpha, and myostatin. It concludes that RT is an effective way to improve muscle strength and the level of synthetic hormones and anti-inflammatory factors in sarcopenic older adults, with a slight impact on body composition and no impact on pro-inflammatory factors.
- |||||||||| Review, Journal: Sarcobesity: new paradigms for healthy aging related to taurine supplementation, gut microbiota and exercise. (Pubmed Central) - Nov 2, 2024
For this reason, further studies are needed that encourage the support of therapeutic management. It is along these lines that we direct the reader to therapeutic approaches that demonstrate important, but still obscure, outcomes in the physiological conditions of sarcobesity, such as the role of taurine in modulating inflammatory and antioxidant mechanisms in muscle and adipose tissue, as well as the management of gut microbiota, able to systemically re-establish the structure and function of the gut-muscle axis, in addition to the merits of physical exercise as an instrument to improve muscular health and lifestyle quality.
- |||||||||| Journal, Adverse events, HEOR: Association between possible sarcopenia, all-cause mortality, and adverse health outcomes in community-dwelling older adults in China. (Pubmed Central) - Oct 30, 2024
In conclusion, in Chinese community-dwelling older adults, possible sarcopenia was associated with an increased risk of all-cause mortality, several chronic diseases, and functional dependence. Thus, alleviating or preventing possible sarcopenia may improve health outcomes and extend the lifespan of these individuals.
- |||||||||| Review, Journal, Surgery: Prognostic value of body composition in oncological visceral surgery (Pubmed Central) - Oct 29, 2024
Rapidly growing evidence shows that body composition parameters, especially reduced muscle mass, are associated with adverse outcomes in cancer patients and have been reported to negatively affect overall survival (OS), disease-free survival (DFS), toxicity associated with chemotherapy and surgical complications. In this article, we summarize the recent literature and present the clinical influence of body composition in oncological visceral diseases.
- |||||||||| Journal: Sarcopenia. (Pubmed Central) - Oct 29, 2024
In this article, we summarize the recent literature and present the clinical influence of body composition in oncological visceral diseases. No abstract available
- |||||||||| Observational data, Journal: Associations of sarcopenia, obesity, and metabolic health with the risk of urinary incontinence in U.S. adult women: a population-based cross-sectional study. (Pubmed Central) - Oct 29, 2024
Metabolically unhealthy status, glycohemoglobin, vitamin D, and serum albumin levels were partial mediators of these associations. Our findings elucidated the complex interactions between sarcopenia, obesity, and metabolic health, underscoring the critical need for integrated therapeutic strategies that address both metabolic health and targeted nutritional interventions, aiming to enhance muscular health and effectively manage and prevent UI.
- |||||||||| oltipraz (PMK-N01GI1) / Canopus BioPharma, Pharmaking
Journal: Heat exposure promotes sarcopenia via gut microbiota-derived metabolites. (Pubmed Central) - Oct 29, 2024 And Nrf2 activator (Oltipraz) supplementation alleviates muscle atrophy and dysfunction induced by heat exposure. Our findings reveal the detrimental effects of heat exposure on muscle function and provide new strategies for treating sarcopenia.
- |||||||||| Review, Journal: Testosterone therapy for functional hypogonadism in middle-aged and elderly males: current evidence and future perspectives. (Pubmed Central) - Oct 28, 2024
Furthermore, there are numerous insightful studies suggesting additional benefits of TTh, for instance in cardio-renal-metabolic conditions. Specifically, future trials should investigate the role of TTh in improving symptoms and prognosis in various clinical contexts, including sarcopenia, frailty, dyslipidemia, arterial hypertension, diabetes mellitus, fracture risk, heart failure, stable angina, chronic kidney disease, mood disorders, and cognitive dysfunction.
|